Report Detail

Pharma & Healthcare Global (United States, European Union and China) Roxatidine Market Research Report 2019-2025

  • RnM3686131
  • |
  • 20 August, 2019
  • |
  • Global
  • |
  • 119 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Roxatidine is a special H2-receptor antagonist, which is mostly prescribed for reflux esophagitis, benign gastric ulcer, duodenal ulcer, and prophylaxis of recurrent ulcers. It is generally classified as an antacid, anti-reflux, or anti-ulcerant drug.
In 2019, the market size of Roxatidine is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Roxatidine.

This report studies the global market size of Roxatidine, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Roxatidine sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Sanofi Aventis
Sihuan Pharmaceutical
Sun Pharmaceutical
Taj Pharmaceuticals
Shin Poong Pharmaceuticals
Sawai Pharmaceutical
...

Market Segment by Product Type
Oral
Injectable

Market Segment by Application
Acidity
Heartburn
Intestinal Ulcers
Stomach Ulcers
Others

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Roxatidine status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Roxatidine manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Roxatidine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025


Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Roxatidine Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Oral
      • 1.3.3 Injectable
    • 1.4 Market Segment by Application
      • 1.4.1 Global Roxatidine Market Share by Application (2019-2025)
      • 1.4.2 Acidity
      • 1.4.3 Heartburn
      • 1.4.4 Intestinal Ulcers
      • 1.4.5 Stomach Ulcers
      • 1.4.6 Others
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Roxatidine Market Size
      • 2.1.1 Global Roxatidine Revenue 2014-2025
      • 2.1.2 Global Roxatidine Sales 2014-2025
    • 2.2 Roxatidine Growth Rate by Regions
      • 2.2.1 Global Roxatidine Sales by Regions 2014-2019
      • 2.2.2 Global Roxatidine Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Roxatidine Sales by Manufacturers
      • 3.1.1 Roxatidine Sales by Manufacturers 2014-2019
      • 3.1.2 Roxatidine Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Roxatidine Revenue by Manufacturers (2014-2019)
      • 3.2.2 Roxatidine Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Roxatidine Market Concentration Ratio (CR5 and HHI)
    • 3.3 Roxatidine Price by Manufacturers
    • 3.4 Key Manufacturers Roxatidine Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Roxatidine Market
    • 3.6 Key Manufacturers Roxatidine Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Oral Sales and Revenue (2014-2019)
      • 4.1.2 Injectable Sales and Revenue (2014-2019)
    • 4.2 Global Roxatidine Sales Market Share by Type
    • 4.3 Global Roxatidine Revenue Market Share by Type
    • 4.4 Roxatidine Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Roxatidine Sales by Application

    6 United States

    • 6.1 United States Roxatidine Breakdown Data by Company
    • 6.2 United States Roxatidine Breakdown Data by Type
    • 6.3 United States Roxatidine Breakdown Data by Application

    7 European Union

    • 7.1 European Union Roxatidine Breakdown Data by Company
    • 7.2 European Union Roxatidine Breakdown Data by Type
    • 7.3 European Union Roxatidine Breakdown Data by Application

    8 China

    • 8.1 China Roxatidine Breakdown Data by Company
    • 8.2 China Roxatidine Breakdown Data by Type
    • 8.3 China Roxatidine Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Roxatidine Breakdown Data by Company
    • 9.2 Rest of World Roxatidine Breakdown Data by Type
    • 9.3 Rest of World Roxatidine Breakdown Data by Application
    • 9.4 Rest of World Roxatidine Breakdown Data by Countries
      • 9.4.1 Rest of World Roxatidine Sales by Countries
      • 9.4.2 Rest of World Roxatidine Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Sanofi Aventis
      • 10.1.1 Sanofi Aventis Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Roxatidine
      • 10.1.4 Roxatidine Product Introduction
      • 10.1.5 Sanofi Aventis Recent Development
    • 10.2 Sihuan Pharmaceutical
      • 10.2.1 Sihuan Pharmaceutical Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Roxatidine
      • 10.2.4 Roxatidine Product Introduction
      • 10.2.5 Sihuan Pharmaceutical Recent Development
    • 10.3 Sun Pharmaceutical
      • 10.3.1 Sun Pharmaceutical Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Roxatidine
      • 10.3.4 Roxatidine Product Introduction
      • 10.3.5 Sun Pharmaceutical Recent Development
    • 10.4 Taj Pharmaceuticals
      • 10.4.1 Taj Pharmaceuticals Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Roxatidine
      • 10.4.4 Roxatidine Product Introduction
      • 10.4.5 Taj Pharmaceuticals Recent Development
    • 10.5 Shin Poong Pharmaceuticals
      • 10.5.1 Shin Poong Pharmaceuticals Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Roxatidine
      • 10.5.4 Roxatidine Product Introduction
      • 10.5.5 Shin Poong Pharmaceuticals Recent Development
    • 10.6 Sawai Pharmaceutical
      • 10.6.1 Sawai Pharmaceutical Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Roxatidine
      • 10.6.4 Roxatidine Product Introduction
      • 10.6.5 Sawai Pharmaceutical Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Roxatidine Sales Channels
      • 11.2.2 Roxatidine Distributors
    • 11.3 Roxatidine Customers

    12 Market Forecast

    • 12.1 Global Roxatidine Sales and Revenue Forecast 2019-2025
    • 12.2 Global Roxatidine Sales Forecast by Type
    • 12.3 Global Roxatidine Sales Forecast by Application
    • 12.4 Roxatidine Forecast by Regions
      • 12.4.1 Global Roxatidine Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Roxatidine Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Summary:
      Get latest Market Research Reports on Roxatidine. Industry analysis & Market Report on Roxatidine is a syndicated market report, published as Global (United States, European Union and China) Roxatidine Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Roxatidine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,280.00
      $4,920.00
      $6,560.00
      2,568.24
      3,852.36
      5,136.48
      3,020.88
      4,531.32
      6,041.76
      514,533.60
      771,800.40
      1,029,067.20
      272,732.00
      409,098.00
      545,464.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report